Latest Exceptional Expenses News & Updates

Mumbai, May 8 (IANS) Pharma company Biocon Limited on Friday reported a 56.8 per cent year-on-year decline in consolidated net profit to Rs 198.6 crore for the fourth quarter ended March 31, 2026, impacted by exceptional expenses related to multiple factors, including the implementation of the new labour code.The biotechnology major had posted a consolidated net profit of Rs 459.4 crore in the corresponding quarter of the previous financial year, according to a regulatory filing by the company.D…